BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15906639)

  • 41. Treatment of acute uncomplicated falciparum malaria with a short course of artesunate followed by mefloquine.
    Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Charoenlarp P; Canfield C; Kyle DE
    Southeast Asian J Trop Med Public Health; 1993 Jun; 24(2):230-4. PubMed ID: 8266223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse effects in patients with acute falciparum malaria treated with artemisinin derivatives.
    Price R; van Vugt M; Phaipun L; Luxemburger C; Simpson J; McGready R; ter Kuile F; Kham A; Chongsuphajaisiddhi T; White NJ; Nosten F
    Am J Trop Med Hyg; 1999 Apr; 60(4):547-55. PubMed ID: 10348227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative pharmacokinetics and effect kinetics of orally administered artesunate in healthy volunteers and patients with uncomplicated falciparum malaria.
    Teja-Isavadharm P; Watt G; Eamsila C; Jongsakul K; Li Q; Keeratithakul G; Sirisopana N; Luesutthiviboon L; Brewer TG; Kyle DE
    Am J Trop Med Hyg; 2001 Dec; 65(6):717-21. PubMed ID: 11791963
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetics of mefloquine administered with artesunate in patients with uncomplicated falciparum malaria from the Brazilian Amazon basin.
    Ferreira MVD; Vieira JLF; Almeida ED; Rivera JGB; Gomes MSM; de Siqueira AM
    Malar J; 2018 Jul; 17(1):268. PubMed ID: 30012152
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative clinical trial of artesunate suppositories and oral artesunate in combination with mefloquine in the treatment of children with acute falciparum malaria.
    Sabchareon A; Attanath P; Chanthavanich P; Phanuaksook P; Prarinyanupharb V; Poonpanich Y; Mookmanee D; Teja-Isavadharm P; Heppner DG; Brewer TG; Chongsuphajaisiddhi T
    Am J Trop Med Hyg; 1998 Jan; 58(1):11-6. PubMed ID: 9452284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phamacokinetics of a single oral dose of dihydroartemisinin in Vietnamese healthy volunteers.
    Le NH; Na-Bangchang K; Le TD; Thrinh KA; Karbwang J
    Southeast Asian J Trop Med Public Health; 1999 Mar; 30(1):11-6. PubMed ID: 10695779
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria.
    Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Suntharasamai P; Charoenlarp P; Arnold K; Kyle D; Canfield C; Webster K
    Lancet; 1992 Apr; 339(8797):821-4. PubMed ID: 1347854
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
    Ashley EA; Krudsood S; Phaiphun L; Srivilairit S; McGready R; Leowattana W; Hutagalung R; Wilairatana P; Brockman A; Looareesuwan S; Nosten F; White NJ
    J Infect Dis; 2004 Nov; 190(10):1773-82. PubMed ID: 15499533
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the safety and relative bioavailability of a new dihydroartemisinin tablet formulation in healthy Thai volunteers.
    Kongpatanakul S; Chatsiricharoenkul S; Sathirakul K; Suputtamongkol Y; Atipas S; Watnasirichaikul S; Pongnarin P; Sangvanich P
    Trans R Soc Trop Med Hyg; 2007 Oct; 101(10):972-9. PubMed ID: 17681360
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Randomized trial of mefloquine-doxycycline, and artesunate-doxycycline for treatment of acute uncomplicated falciparum malaria.
    Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Charoenlarp P; Canfield CJ; Kyle DE
    Am J Trop Med Hyg; 1994 Jun; 50(6):784-9. PubMed ID: 8024075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetic and pharmacodynamic interactions of mefloquine and dihydroartemisinin.
    Na-Bangchang K; Tippawangkosol P; Thanavibul A; Ubalee R; Karbwang J
    Int J Clin Pharmacol Res; 1999; 19(1):9-17. PubMed ID: 10450538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Artesunate suppositories versus intramuscular artemether for treatment of severe malaria in children in Papua New Guinea.
    Karunajeewa HA; Reeder J; Lorry K; Dabod E; Hamzah J; Page-Sharp M; Chiswell GM; Ilett KF; Davis TM
    Antimicrob Agents Chemother; 2006 Mar; 50(3):968-74. PubMed ID: 16495259
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
    McGready R; Stepniewska K; Ward SA; Cho T; Gilveray G; Looareesuwan S; White NJ; Nosten F
    Eur J Clin Pharmacol; 2006 May; 62(5):367-71. PubMed ID: 16552504
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics/Pharmacodynamics findings after repeated administration of ARTESUNATE thermostable suppositories (RECTOCAPS) in Vietnamese patients with uncomplicated malaria.
    Benakis A; Binh TQ; Keundjian A; Scheiwe MW
    Eur J Drug Metab Pharmacokinet; 2006; 31(1):41-5. PubMed ID: 16715782
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mathematical modelling of malaria chemotherapy: combining artesunate and mefloquine.
    Hoshen MB; Stein WD; Ginsburg H
    Parasitology; 2002 Jan; 124(Pt 1):9-15. PubMed ID: 11811806
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria.
    Tangpukdee N; Krudsood S; Thanachartwet W; Chalermrut K; Pengruksa C; Srivilairit S; Silachamroon U; Wilairatana P; Phongtananant S; Kano S; Looareesuwan S
    Southeast Asian J Trop Med Public Health; 2005 Sep; 36(5):1085-91. PubMed ID: 16438129
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Systematic review of artesunate pharmacokinetics: Implication for treatment of resistant malaria.
    Kouakou YI; Tod M; Leboucher G; Lavoignat A; Bonnot G; Bienvenu AL; Picot S
    Int J Infect Dis; 2019 Dec; 89():30-44. PubMed ID: 31491558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria.
    Batty KT; Le AT; Ilett KF; Nguyen PT; Powell SM; Nguyen CH; Truong XM; Vuong VC; Huynh VT; Tran QB; Nguyen VM; Davis TM
    Am J Trop Med Hyg; 1998 Nov; 59(5):823-7. PubMed ID: 9840605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Disposition of artesunate and dihydroartemisinin after administration of artesunate suppositories in children from Papua New Guinea with uncomplicated malaria.
    Karunajeewa HA; Ilett KF; Dufall K; Kemiki A; Bockarie M; Alpers MP; Barrett PH; Vicini P; Davis TM
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2966-72. PubMed ID: 15273107
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative clinical trial of artesunate followed by mefloquine in the treatment of acute uncomplicated falciparum malaria: two- and three-day regimens.
    Looareesuwan S; Viravan C; Vanijanonta S; Wilairatana P; Pitisuttithum P; Andrial M
    Am J Trop Med Hyg; 1996 Feb; 54(2):210-3. PubMed ID: 8619450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.